- Home
- NUVB vs PSFE Comparison
NUVB vs PSFE Comparison
Compare NUVB & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- PSFE
- Stock Information
- Founded
- NUVB 2018
- PSFE 1996
- Country
- NUVB United States
- PSFE United Kingdom
- Employees
- NUVB N/A
- PSFE N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- PSFE Business Services
- Sector
- NUVB Health Care
- PSFE Consumer Discretionary
- Exchange
- NUVB Nasdaq
- PSFE Nasdaq
- Market Cap
- NUVB 679.9M
- PSFE 770.7M
- IPO Year
- NUVB N/A
- PSFE N/A
- Fundamental
- Price
- NUVB $2.09
- PSFE $13.45
- Analyst Decision
- NUVB Strong Buy
- PSFE Sell
- Analyst Count
- NUVB 6
- PSFE 4
- Target Price
- NUVB $7.83
- PSFE $17.38
- AVG Volume (30 Days)
- NUVB 8.9M
- PSFE 401.8K
- Earning Date
- NUVB 08-04-2025
- PSFE 08-12-2025
- Dividend Yield
- NUVB N/A
- PSFE N/A
- EPS Growth
- NUVB N/A
- PSFE N/A
- EPS
- NUVB N/A
- PSFE N/A
- Revenue
- NUVB $10,957,000.00
- PSFE $1,688,097,000.00
- Revenue This Year
- NUVB $101.21
- PSFE $2.88
- Revenue Next Year
- NUVB $410.28
- PSFE $6.73
- P/E Ratio
- NUVB N/A
- PSFE N/A
- Revenue Growth
- NUVB N/A
- PSFE 3.50
- 52 Week Low
- NUVB $1.54
- PSFE $11.60
- 52 Week High
- NUVB $3.97
- PSFE $26.25
- Technical
- Relative Strength Index (RSI)
- NUVB 51.54
- PSFE 57.97
- Support Level
- NUVB $1.87
- PSFE $12.45
- Resistance Level
- NUVB $2.10
- PSFE $13.48
- Average True Range (ATR)
- NUVB 0.16
- PSFE 0.49
- MACD
- NUVB 0.01
- PSFE 0.17
- Stochastic Oscillator
- NUVB 91.23
- PSFE 88.00
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.